Global Ferritin Testing Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Ferritin Testing Market Analysis

The ferritin testing market is experiencing steady growth, driven by increasing awareness about iron deficiency and its related disorders such as anemia. Ferritin is a key biomarker used to assess iron levels in the body, making it crucial for diagnosing various health conditions. The market is benefiting from advancements in diagnostic technologies, such as improved assays and more accurate testing devices. These innovations allow for faster, more reliable results, contributing to the widespread adoption of ferritin testing in hospitals, diagnostic laboratories, and specialty clinics. Recent advancements include the development of point-of-care ferritin tests, which enable quick and efficient testing in various healthcare settings. In addition, the integration of ferritin testing with broader health panels, including those for COVID-19-related conditions, has expanded its applications. Companies such as Abbott, BIOMÉRIEUX, and Eurolyser Diagnostica GmbH are leading the way in providing advanced diagnostic tools. Geographically, North America dominates the market due to a high prevalence of iron deficiency disorders among the aging population, while the Asia-Pacific region is expected to show rapid growth, driven by rising healthcare awareness and increased spending on healthcare. The global market for ferritin testing is poised for significant growth as awareness and healthcare accessibility continue to rise worldwide.

Ferritin Testing Market Size

The global ferritin testing market size was valued at USD 3.37 billion in 2024 and is projected to reach USD 5.09 billion by 2032, with a CAGR of 5.30% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Ferritin Testing Market Trends

“Increasing Shift toward Point-Of-Care Testing (POCT)”

The global ferritin testing market is expanding rapidly due to the increasing awareness of iron deficiency disorders and advancements in diagnostic technologies. One notable trend is the shift toward point-of-care testing (POCT), which enables quick and convenient ferritin testing outside of traditional laboratory settings. This trend is gaining traction, especially in regions with limited access to healthcare infrastructure. For instance, Abbott has developed portable ferritin testing devices that provide accurate results in real-time, making it easier for healthcare providers to diagnose iron deficiency and related conditions. In addition, the rising incidence of iron deficiency anemia and its associated health complications, particularly in aging populations, is fueling demand for ferritin tests. In North America, where iron deficiency is a significant health concern, the market is growing rapidly, with an increasing number of hospitals and diagnostic laboratories adopting advanced ferritin testing solutions. As a result, the global ferritin testing market is poised for continued growth, driven by technological innovations and rising healthcare awareness.

Report Scope and Ferritin Testing Market Segmentation      

Ferritin Testing Market Definition

Ferritin testing is a diagnostic procedure used to measure the level of ferritin, a protein that stores iron in the body. Ferritin levels are an important indicator of the body’s iron stores and are used to diagnose and monitor various conditions related to iron deficiency or overload, such as iron deficiency anemia, hemochromatosis, and chronic diseases. Low ferritin levels often indicate iron deficiency, while elevated levels may suggest iron overload or conditions such as liver disease, inflammation, or chronic illness. The test is typically performed using blood samples, and the results help healthcare providers assess the body's iron status, guide treatment plans, and track disease progression.

Ferritin Testing Market Dynamics

Drivers

• Rising Prevalence of Iron Deficiency Disorders

The rising prevalence of iron deficiency disorders, particularly iron deficiency anemia, is a significant driver for the growth of the ferritin testing market. According to the World Health Organization (WHO), iron deficiency anemia affects approximately 1.62 billion people worldwide, making it one of the most common nutritional disorders, with women, children, and the elderly being the most vulnerable groups. For instance, in developing regions such as sub-Saharan Africa and South Asia, the incidence of iron deficiency is notably high due to factors such as poor dietary intake, malnutrition, and limited access to healthcare. This widespread prevalence increases the demand for accurate diagnostic tools such as ferritin tests to assess iron stores and diagnose related conditions. As iron deficiency becomes a growing health concern globally, particularly in underserved areas, there is an increasing need for efficient and accessible ferritin testing. Consequently, this rising incidence is driving market demand as healthcare providers seek reliable methods to detect and monitor iron deficiency and anemia in affected populations.

• Rising Aging Global

The aging global population is significantly contributing to the growth of the ferritin testing market, as older adults are more prone to iron deficiency-related disorders, such as anemia. According to the World Health Organization (WHO), anemia affects approximately 25% of the global population, with a higher prevalence in the elderly. In older adults, iron deficiency anemia can result from factors such as poor dietary intake, chronic diseases, or the side effects of medications. As people age, the risk of developing these conditions increases, driving the need for regular screening and ferritin testing to monitor iron levels. For instance, a study published in the Journal of Clinical Nutrition found that nearly 10-20% of older adults are affected by iron deficiency. As a result, healthcare providers are increasingly relying on ferritin testing to accurately diagnose and manage these conditions, further boosting the demand for ferritin testing devices. This growing need for diagnostic tools in an aging population serves as a significant market driver for ferritin testing.

Opportunities

• Growing Healthcare Awareness

Growing healthcare awareness is a key factor driving the adoption of ferritin testing, as more people recognize the importance of monitoring iron levels for overall health. Public health campaigns and educational initiatives are playing a crucial role in raising awareness about conditions such as anemia, iron deficiency, and their potential links to chronic diseases. For instance, the World Health Organization (WHO) has highlighted the global burden of iron deficiency anemia, particularly in women and children, leading to widespread educational efforts to promote early detection and prevention. In the U.S., campaigns by organizations such as the National Heart, Lung, and Blood Institute (NHLBI) focus on raising awareness about the importance of iron levels in preventing long-term health issues. As awareness increases, more individuals are seeking regular checkups and diagnostic tests, including ferritin testing, to monitor their iron status. This growing awareness creates a significant market opportunity for healthcare providers and diagnostic companies offering ferritin testing solutions, contributing to the market's expansion.

• Improved Healthcare Infrastructure

Improved healthcare infrastructure, especially in emerging markets, is driving the increased adoption of advanced diagnostic tools such as ferritin testing. As countries such as India, China, and Brazil invest in expanding healthcare access and improving medical facilities, there is a growing demand for accurate and reliable diagnostic solutions. For instance, in India, the government’s National Health Mission and private sector investments have significantly increased access to healthcare services in rural areas, leading to a higher adoption of diagnostic tests. Similarly, in China, the government’s focus on modernizing healthcare infrastructure, coupled with the rise of private hospitals, has fueled the demand for advanced diagnostic technologies, including ferritin testing. The expansion of both public health initiatives and private healthcare services is providing a significant market opportunity for companies that offer ferritin testing devices and solutions, as more people seek comprehensive diagnostic options. This growth in healthcare infrastructure is enhancing accessibility and fostering the adoption of cutting-edge diagnostic tools, driving the global ferritin testing market.

Restraints/Challenges

• High Costs of Ferritin Testing

The ferritin testing cost is a significant market challenge, particularly in low-resource settings where healthcare budgets are constrained. Ferritin tests, when conducted in specialized laboratories, involve the cost of the test itself and laboratory fees, equipment, reagents, and skilled personnel to interpret the results. For instance, in many developing countries, where iron deficiency anemia and other iron-related disorders are prevalent, the expense of ferritin testing can exceed the financial capabilities of both healthcare systems and individual patients. This high cost limits accessibility to accurate diagnostics, resulting in delays in diagnosing conditions such as iron deficiency anemia or iron overload disorders such as hemochromatosis. In turn, patients may face a lack of timely intervention, leading to worsened health outcomes. The prohibitive cost of ferritin testing in resource-limited regions, along with the limited availability of affordable testing solutions, is a key challenge that hinders the broader adoption of ferritin testing globally, limiting the market's growth potential and the ability to address iron-related health issues effectively.

• Stringent Regulations and Approval Processes

Regulatory hurdles are a significant challenge in the ferritin testing market, as the development of new test kits or methods requires approval from stringent regulatory bodies such as the U.S. FDA or the European Medicines Agency (EMA). The approval process for diagnostic tests is time-consuming and costly, involving extensive clinical trials, validation, and documentation to demonstrate the safety and efficacy of the test. For instance, a new ferritin test kit designed to provide faster results or higher accuracy might face delays due to the lengthy regulatory review process, especially if the test involves novel technology or requires additional studies to meet safety standards. These delays increase development costs and postpone the availability of potentially improved diagnostic solutions, limiting the pace of innovation within the market. As a result, regulatory barriers can slow market growth by preventing the quick introduction of new, more efficient, or cost-effective ferritin testing options, ultimately affecting healthcare providers’ ability to offer timely and reliable diagnostic tools to patients.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Ferritin Testing Market Scope

The market is segmented on the basis of product, indication, and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Instrument
• Reagent
• Kits

Indication

• Anemia
• Hemochromatosis
• Pregnancy
• Lead Poisoning

End User

• Hospitals
• Diagnostic Laboratories
• Specialty Clinics

Ferritin Testing Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, product, indication, and end user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America leads the ferritin testing market, driven by the growing geriatric population and the increasing prevalence of iron deficiency disorders among older adults. As the aging population expands, conditions such as anemia and iron deficiency become more common, creating a higher demand for ferritin testing. In addition, greater awareness and advancements in healthcare have led to more widespread

Asia-Pacific is expected to experience rapid and lucrative growth in the ferritin testing market during the forecast period from 2025 to 2032. This growth can be attributed to increasing healthcare awareness among the population and a significant rise in healthcare spending across countries in the region. As more people become aware of the importance of early disease detection, the demand for diagnostic tests, including ferritin testing, is growing. In addition, government initiatives and investments in healthcare infrastructure are further boosting the adoption of advanced diagnostic solutions.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Ferritin Testing Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Ferritin Testing Market Leaders Operating in the Market Are:

• Abbott (U.S.)
• Eurolyser Diagnostica GmbH (Austria)
• Diagnostic Automation/Cortez Diagnostics Inc. (U.S.)
• BIOMÉRIEUX (France)
• Doctorcall (U.K.)
• AAviva Systems Biology Corporation (U.S.)
• Abnova Corporation (Taiwan)
• Biopanda Reagents Ltd (U.K.)
• Biocompare (U.S.)

Latest Developments in Ferritin Testing Market

• In November 2024, LordsMed, a leading healthcare division of Lords Mark Industries Pvt. Ltd., launched its first pathology center in Kalyan, followed by another center in Dombivli. LordsMed Pathology Lab aims to maintain a high standard of accuracy in testing, supported by its in-house Research and Development (R&D) team, which focuses on researching reagents and chemicals for various diagnostic tests, including Ferritin Testing
• In May 2023, Quest Diagnostics introduced two Post-COVID-19 panels, the Post-COVID-19 Basic Panel and the Post-COVID-19 Expanded Test Panel, to help consumers assess lingering health issues related to previous COVID-19 infections. The Expanded Test Panel includes tests for ferritin levels, providing consumers with valuable insights for discussions with their healthcare providers
• In May 2022, Bloom Diagnostics participated in the ASICS Austrian Women's Run, offering the Bloom Thyroid Test and Bloom Ferritin Test to over 18,000 participants. The event emphasized women's health and athletic performance, making it a significant occasion for Bloom
• In February 2022, Western Cape Blood Service introduced ferritin testing for all blood donors throughout the year, aiming to enhance donor health and optimize blood donation processes

SKU-66482